스마트 체외진단 시장 : 체외진단 시장의 인공지능 - 용도별, 기술별, 장소별, 제품별 - 경영진 및 컨설턴트 가이드 포함(2025-2029년)

Artificial Intelligence will drive IVD market growth over the next 20 years. The market is exploding as physicians use all the information they can get to battle disease. While Pharmaceutical Companies see the potential to make nearly any therapy viable. Find out how this new approach to diagnostics will change medical care forever.

Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of many commodity diagnostics continues to fall.

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. What are Smart Diagnostics?
• 2.2. Market Definition
  • 2.2.1. Revenue Market Size
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Market Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Understanding Artificial Intelligence
  • 3.2.1. Artificial intelligence
  • 3.2.2. Machine learning
  • 3.2.3. Deep learning
  • 3.2.4. Convolutional neural networks
  • 3.2.5. Generative adversarial networks
  • 3.2.6. Limitations
• 3.3. AI Applications in IVD
  • 3.3.1. Infectious Disease
    • 3.3.1.1. Known vs. Unknown
    • 3.3.1.2. TMI
    • 3.3.1.3. Disease surveillance
    • 3.3.1.4. Outbreak detection
    • 3.3.1.5. Contact tracing
    • 3.3.1.6. Forecasting
    • 3.3.1.7. Drug discovery
    • 3.3.1.8. Resource allocation
  • 3.3.2. Oncology
    • 3.3.2.1. Electronic health records
    • 3.3.2.2. Genomic analysis
    • 3.3.2.3. Treatment planning
    • 3.3.2.4. Clinical trial matching
  • 3.3.3. Anatomic Pathology
    • 3.3.3.1. Image analysis
    • 3.3.3.2. Tumor segmentation
    • 3.3.3.3. Disease classification
    • 3.3.3.4. Predictive modeling
    • 3.3.3.5. Quality control
    • 3.3.3.6. Digital pathology
  • 3.3.4. Cardiology
    • 3.3.4.1. Electrocardiogram analysis
    • 3.3.4.2. Electronic health records
    • 3.3.4.3. Genomic analysis
    • 3.3.4.4. Treatment planning
    • 3.3.4.5. Prediction of outcomes
  • 3.3.5. Diabetes
    • 3.3.5.1. Diagnosis
    • 3.3.5.2. Blood glucose monitoring
    • 3.3.5.3. Personalized treatment plans
    • 3.3.5.4. Medication management
    • 3.3.5.5. Diabetes education
    • 3.3.5.6. Predictive analytics
  • 3.3.6. General Medicine
    • 3.3.6.1. Diagnosis
    • 3.3.6.2. Predictive Analytics
    • 3.3.6.3. Personalized Treatment Plans
    • 3.3.6.4. Medication Management
    • 3.3.6.5. Disease Monitoring
    • 3.3.6.6. Telemedicine

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. Outcome Improvement
  • 4.1.2. The Aging Effect
  • 4.1.3. Cost Containment
  • 4.1.4. Physician Impact
  • 4.1.5. Cost of Intelligence
• 4.2. Factors Limiting Growth
  • 4.2.1. State of knowledge
  • 4.2.2. Genetic Blizzard
  • 4.2.3. Protocol Resistance
  • 4.2.4. Regulation and coverage
• 4.3. Instrumentation, Automation and Diagnostic Trends
  • 4.3.1. Traditional Automation and Centralization
  • 4.3.2. The New Automation, Decentralization and Point Of Care
  • 4.3.3. Instruments Key to Market Share
  • 4.3.4. Bioinformatics Plays a Role
  • 4.3.5. PCR Takes Command
  • 4.3.6. Next Generation Sequencing Fuels a Revolution
  • 4.3.7. NGS Impact on Pricing
  • 4.3.8. Whole Genome Sequencing, A Brave New World
  • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10. Shifting Role of Diagnostics

5. Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Ataraxis AI Nabs Financing
• 5.3. Myriad Genetics Licenses Image Analysis Technology
• 5.4. Danaher, AI Firm I Form Investment Partnership
• 5.5. Cardio Dx AI-Based Tests Receive Final CMS Pricing
• 5.6. Ataraxis AI Launches AI Cancer Dx
• 5.7. Tempus Immuno-Oncology Portfolio AI-enabled
• 5.8. AI enables precision diagnosis of cervical cancer
• 5.9. UK to Rollout Digital Pathology Across NHS
• 5.10. AI Based Next-Generation Colorectal Cancer Test
• 5.11. Evident, Corista, Sakura Finetek, Visiopharm Form Digital Pathology Alliance
• 5.12. Viome Life Sciences Raises $86.5M in Oversubscribed Series C Round
• 5.13. Becton Dickinson Gets Clearance for AI-Based Bacterial Imaging
• 5.14. Paige, Leica Biosystems Expand Digital Pathology Partnership
• 5.15. Clarapath Acquires Digital Pathology Company Crosscope
• 5.16. CanSense to Develop Colorectal Cancer Test
• 5.17. Owkin-led Machine Learning Study IDs Cancer Treatment Biomarkers
• 5.18. Guardant Health to Integrate Lunit's AI PD-L1 Algorithm
• 5.19. Vesale Bioscience to Develop AI Phage Therapy Diagnostic Platform
• 5.20. Caris Life Sciences To Use AI and Machine Learning
• 5.21. Numares Health To Develop AI for "Metabolite Constellations"
• 5.22. Sepsis Testing Startup DeepUll to Use AI for Medical Decisions
• 5.23. Viome Life Sciences Raises $67M in Series C Financing For AI Cancer Dx
• 5.24. ADM Diagnostics Wins Grant for Brain Injury Test Development
• 5.25. Paige to Develop New AI-based Pathology Test
• 5.26. Aiforia Gains CE-IVD Mark for AI-Powered Histopathology
• 5.27. Genetic Profiling May Identify Patients Who Do Not Need Radiation Therapy
• 5.28. Thermo Fisher Introduces Homologous Score for Cancer Profiling
• 5.29. Genomic Test IDs Cancer Cells Early

6. Profiles of Key Players

• 6.1. Adaptive Biotechnologies
• 6.2. Aidoc
• 6.3. Anumana
• 6.4. ARUP Laboratories
• 6.5. Atomwise
• 6.6. Bayesian Health
• 6.7. Behold.ai
• 6.8. BGI Genomics Co. Ltd
• 6.9. bioMerieux Diagnostics
• 6.10. Bio-Rad Laboratories, Inc
• 6.11. Cambridge Cognition
• 6.12. Cardiologs (Phillips)
• 6.13. CareDx
• 6.14. Caris Molecular Diagnostics
• 6.15. Cleerly
• 6.16. ClosedLoop AI
• 6.17. CloudMedX Health
• 6.18. Deepcell
• 6.19. Digital Diagnostics
• 6.20. EKF Diagnostics Holdings
• 6.21. Freenome
• 6.22. GE Healthcare
• 6.23. Glooko
• 6.24. Idoven
• 6.25. Illumina
• 6.26. Infohealth
• 6.27. Jade
• 6.28. K Health
• 6.29. Lunit
• 6.30. Luventix
• 6.31. MaxCyte
• 6.32. Mayo Clinic Laboratories
• 6.33. Medtronic
• 6.34. Merative
• 6.35. Nanox
• 6.36. NIOX Group
• 6.37. Niramai Health Analytix
• 6.38. NVIDIA
• 6.39. Oncohost
• 6.40. OraLiva
• 6.41. Owkin
• 6.42. Oxford Nanopore Technologies
• 6.43. Pacific Biosciences
• 6.44. Paige.AI
• 6.45. PathAI
• 6.46. Perthera
• 6.47. Philips Healthcare
• 6.48. Prognos
• 6.49. Qiagen
• 6.50. Qure.ai
• 6.51. Renalytix
• 6.52. Seegene
• 6.53. Siemens Healthineers
• 6.54. Sophia Genetics
• 6.55. Sysmex
• 6.56. Viz.ai

7. The Global Market for Smart Diagnostics

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market by Application - Overview
  • 7.2.1. Table - Global Market by Application
  • 7.2.2. Chart - Global Market by Application - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Application - Base Year
  • 7.2.4. Chart - Global Market by Application - Final Year
  • 7.2.5. Chart - Global Market by Application - Share by Year
  • 7.2.6. Chart - Global Market by Application - Segment Growth
• 7.3. Global Market by Technology - Overview
  • 7.3.1. Table - Global Market by Technology
  • 7.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market by Technology - Base Year
  • 7.3.4. Chart - Global Market by Technology - Final Year
  • 7.3.5. Chart - Global Market by Technology - Share by Year
  • 7.3.6. Chart - Global Market by Technology - Segment Growth
• 7.4. Global Market by Place - Overview
  • 7.4.1. Table - Global Market by Place
  • 7.4.2. Chart - Global Market by Place - Base/Final Year Comparison
  • 7.4.3. Chart - Global Market by Place - Base Year
  • 7.4.4. Chart - Global Market by Place - Final Year
  • 7.4.5. Chart - Global Market by Place - Share by Year
  • 7.4.6. Chart - Global Market by Place - Segment Growth
• 7.5. Global Market by Product - Overview
  • 7.5.1. Table - Global Market by Product
  • 7.5.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 7.5.3. Chart - Global Market by Product - Base Year
  • 7.5.4. Chart - Global Market by Product - Final Year
  • 7.5.5. Chart - Global Market by Product - Share by Year
  • 7.5.6. Chart - Global Market by Product - Segment Growth

8. Global Markets - By Application

• 8.1. Cancer
  • 8.1.1. Table Cancer Testing - by Country
  • 8.1.2. Chart - Cancer Testing Growth
• 8.2. Infectious Disease Testing
  • 8.2.1. Table Infectious Disease Testing - by Country
  • 8.2.2. Chart - Infectious Disease Testing Growth
• 8.3. Metabolic Testing
  • 8.3.1. Table Metabolic Testing - by Country
  • 8.3.2. Chart - Metabolic Testing Growth
• 8.4. Cardiac Testing
  • 8.4.1. Table Cardiac Testing - by Country
  • 8.4.2. Chart - Cardiac Testing Growth
• 8.5. Diabetes Testing
  • 8.5.1. Table Diabetes Testing - by Country
  • 8.5.2. Chart - Diabetes Testing Growth
• 8.6. Other Disease Testing
  • 8.6.1. Table Other Disease Testing - by Country
  • 8.6.2. Chart - Other Disease Testing Growth

9. Global Markets - By Technology

• 9.1. NGS Technology
  • 9.1.1. Table NGS Technology - by Country
  • 9.1.2. Chart - NGS Technology Growth
• 9.2. PCR Technology
  • 9.2.1. Table PCR Technology - by Country
  • 9.2.2. Chart - PCR Technology Growth
• 9.3. Chemistry/IA Technology
  • 9.3.1. Table Chemistry/IA Technology - by Country
  • 9.3.2. Chart - Chemistry/IA Technology Growth
• 9.4. Pathology Technology
  • 9.4.1. Table Pathology Technology - by Country
  • 9.4.2. Chart - Pathology Technology Growth
• 9.5. Other Technology
  • 9.5.1. Table Other Technology - by Country
  • 9.5.2. Chart - Other Technology Growth

10. Global Markets - By Place

• 10.1. Research
  • 10.1.1. Table Research - by Country
  • 10.1.2. Chart - Research Growth
• 10.2. Pharmaceutical Research
  • 10.2.1. Table Pharmaceutical Research - by Country
  • 10.2.2. Chart - Pharmaceutical Research Growth
• 10.3. Clinical
  • 10.3.1. Table Clinical - by Country
  • 10.3.2. Chart - Clinical Growth
• 10.4. Other Place
  • 10.4.1. Table Other Place - by Country
  • 10.4.2. Chart - Other Place Growth

11. Global Markets - By Product

• 11.1. Instruments
  • 11.1.1. Table Instruments - by Country
  • 11.1.2. Chart - Instruments Growth
• 11.2. Assay
  • 11.2.1. Table Assay - by Country
  • 11.2.2. Chart - Assay Growth
• 11.3. Software
  • 11.3.1. Table Software - by Country
  • 11.3.2. Chart - Software Growth
• 11.4. Services
  • 11.4.1. Table Services - by Country
  • 11.4.2. Chart - Services Growth
• 11.5. Other Product
  • 11.5.1. Table Other Product - by Country
  • 11.5.2. Chart - Other Product Growth

12. Appendices

• 12.1. United States Clinical Laboratory Fees Schedule
  • 12.1.1. Laboratory Fees Schedule
  • 12.1.2. The Most Used IVD Assays
  • 12.1.3. The Highest Grossing Assays